CYP1A2
From SNPedia
| is a | gene |
| is | mentioned by |
| wikipedia | CYP1A2 |
| CYP1A2 | |
| gopubmed | CYP1A2 |
| 23andMe | CYP1A2 |
dbSNP 1544
PubMed 1544
SADR 1544
HugeNav 1544
HEFalMp CYP1A2
| Chromosome position | Summary | |
|---|---|---|
| Rs12720461 | 7282840372,828,403 | |
| Rs2069514 | 7282527272,825,272 | |
| Rs2069521 | 7282601972,826,019 | |
| Rs2069526 | 7282839372,828,393 | |
| Rs2470890 | 7283447872,834,478 | |
| Rs28399424 | 7283422172,834,221 | |
| Rs762551 | 7282896972,828,969 |
The CYP1A2 gene encodes a member of the cytochrome p450 family of proteins, which metabolize nutrients and drugs. One well known substrate of CYP1A2 is caffeine; individuals who are carry one or more CYP1A2*1C alleles are "slow" caffeine metabolizers, whereas carriers of the variant CYP1A2*1F are "fast" caffeine metabolizers. The same amount of caffeine will therefore tend to have more stimulating effect on CYP1A2 slow metabolizers than on CYP1A2 fast metabolizers.
CYP1A2 can also be stimulated or inhibited by numerous medications and food-drug interactions. Fluoroquinolones, for example, are both metabolized by, and inhibit, the CYP1A2 enyzyme. This can slow the breakdown of caffeine, for example, leading to caffeine overstimulation. Conversely, smoking is a well-known activator of CYP1A2 (especially the CYP1A2*1F form), resulting in faster breakdown of drugs metabolized by CYP1A2 and the possibility of insufficient drug concentrations in the body to yield much therapeutic benefit.
Alleles of CYP1A2 include:
| Allele Name | Rs# | Comments | Platforms |
|---|---|---|---|
| CYP1A2*1 | n/a | the prototypical allele | |
| CYP1A2*1C | rs2069514 | decreased activity; also known as -3860G>A | |
| CYP1A2*1D | rs35694136 | ||
| CYP1A2*1F | rs762551 | increased activity; also known as -163C>A | 23andMe v1, 23andMe v2, Illumina Human 1M |
| CYP1A2*1K_-729C>T | rs12720461 | decreased activity | 23andMe v1, 23andMe v2, HumanOmni1Quad, Illumina Human 1M |
| CYP1A2*1K_-739T>G | rs2069526 | apparently decreased activity | 23andMe v1, 23andMe v2, HumanOmni1Quad, Illumina Human 1M |
| CYP1A2*2_63C>G | |||
| CYP1A2*3 | rs56276455 | decreased activity; also known as D348N | |
| CYP1A2*4 | rs72547516 | decreased activity; also known as I386F | |
| CYP1A2*5 | rs55889066 | also known as C406Y | |
| CYP1A2*6 | rs28399424 | decreased activity; also known as R431W | 23andMe v1, 23andMe v2, HumanOmni1Quad, Illumina Human 1M |
| CYP1A2*7_3534G>A | decreased activity; may be 3533G>A | ||
| CYP1A2*8 | rs72547517 | also known as R456H | |
| CYP1A2*11 | rs72547513 | also known as F186L | |
| CYP1A2*15 | rs72547511 | also known as P42R | |
| CYP1A2*16 | rs72547515 | also known as R377Q | |
| CYP1A2_1545T>C | rs2470890 | 23andMe v2, Affy GenomeWide 6 |